Impact of chronic kidney disease on the prognosis of patients undergoing percutaneous coronary interventions using drug-eluting stents

Clinical Research in Cardiology

Volumn 100, Issue 12, 2011, Pages 1103-1109

  Kaya, Elif ^a   Cuneo, Alessandro ^b   Hochadel, Matthias ^c   Jünger, Claus ^c   Stepper, Wibke ^a   Bramlage, Peter ^d   Kuck, Karl Heinz ^e   Nienaber, Christoph A ^f   Senges, Jochen ^c   Eckardt, Lars ^a   Tebbe, Ulrich ^b   Reinecke, Holger ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b KLINIKUM LIPPE DETMOLD   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d Institute for Cardiovascular Pharmacology and Epidemiology   (Germany)

^e Asklepios Hospital Hamburg   (Germany)

^f ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

Angioplasty; Chronic kidney disease; Drug eluting stents; Mortality; PCI

Indexed keywords

RAPAMYCIN;

ACUTE CORONARY SYNDROME; ACUTE DISEASE; ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLEEDING; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG ELUTING STENT; FEMALE; GERMANY; HEALTH CARE SYSTEM; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROSPECTIVE STUDY; REGISTER; RESTENOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL; TREATMENT OUTCOME;

AGED; ANALYSIS OF VARIANCE; ANGIOPLASTY, BALLOON, CORONARY; CHRONIC DISEASE; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; GERMANY; HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REGISTRIES; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84856014185     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-011-0347-7     Document Type: Article

References (25)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296-1305
2. Reinecke H, Trey T, Matzkies F, Fobker M, Breithardt G, Schaefer RM (2003) Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions. Kidney Int 63:696-701 (Pubitemid 36131112)
3. Muntner P, He J, Hamm L, Loria C, Whelton PK (2002) Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13:745-753 (Pubitemid 34183941)
4. Lemos PA, Arampatzis CA, Hove A et al (2005) Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol 95:167-172 (Pubitemid 40092079)
5. Kuchulakanti PK, Torguson R, Chu WW et al (2006) Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutanous coronary intervention with sirolimuseluting stents versus bare metal stents. Am J Cardiol 97:792-797
6. Nienaber CA, Akin I, Schneider S et al (2009) Clinical outcomes after sirolimus-eluting, paclitaxel-eluting and bare-metal stents in a real world setting (from the first phase of the prospective multicenter German DES.DE Registry). Am J Cardiol 104:1362-1369
7. Baigent C, Burbury K, Wheeler D (2000) Premature cardiovascular disease in chronic renal failure. Lancet 356:147-152 (Pubitemid 30438520)
8. Reddan DN, Szczech LA, Tuttle RH, Shaw LK, Jones RH, Schwab SJ, Smith MS, Califf RM, Mark DB, Owen WF Jr (2003) Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol 14:2373-2380 (Pubitemid 37052385)
9. Reddan DN, Marcus RJ, Owen WF Jr, Szczech LA, Landwehr DM (2001) Long-term outcomes of revascularization for peripheral vascular disease in end-stage renal disease patients. Am J Kidney Dis 38:57-63 (Pubitemid 32611759)
10. Herzog CA, Ma JZ, Collins AJ (2002) Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 106:2207-2211 (Pubitemid 35222214)
11. Keeley EC, Kadakia R, Soman S, Borzak S, McCullough PA (2003) Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 92:509-514 (Pubitemid 37013400)
12. Yachi S, Tanabe K, Tanimoto S et al (2009) Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients. Am J Kidney Dis 54:299-306
13. Syed AI, Ben-Dor I, Collins SD et al (2010) Sirolimus-eluting stent versus paclitaxel-eluting stents in patients with chronic renal insufficiency. J Inter Cardiol 23:33-39
14. Jeong YH, Hong MK, Lee CW et al (2008) Impact of significant chronic kidney disease on long-term clinical outcomes after drugeluting stent versus bare metal stent implantation. Int J Cardiol 125:36-40 (Pubitemid 351305425)
15. Best PJ, Berger PB, Davis BR et al (2004) Impact of mild or moderate chronic kidney disease on the frequency of restenosis: Results from the PRESTO trial. J Am Coll Cardiol 44:1786-1791 (Pubitemid 39424076)
16. Blackman DJ, Pinto R, Ross JR et al (2006) Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention. Am Heart J 151:146-152 (Pubitemid 41815345)
17. Halkin A, Mehran R, Casey CW et al (2005) Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: Results from the TAXUS-IV Trial. Am Heart J 150:1163-1170 (Pubitemid 41773517)
18. Ota T, Umeda H, Yokota S et al (2009) Relationship between severity of renal impairment and 2-year outcomes after sirolimuseluting stent implantation. Am Heart J 158:92-98
19. Morice MC, Serruys PW, Sousa JE et al (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773-1780 (Pubitemid 34586912)
20. Degertekin M, Serruys PW, Foley DP et al (2002) Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: Long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up. Circulation 106:1610-1613
21. Lee MS, Canan T, Perlowski A, Bhatia R, Jurewitz D, Tobis JM (2009) Causes of death in patients undergoing percutaneous coronary intervention with drug-eluting stents in a real-world setting. J Invasive Cardiol 21:41-445
22. Reinecke H, Brand E, Mesters R et al (2009) Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol 20:705-711
23. Appleby CE, Ivanov J, Lavi S et al (2009) The adverse long-term impact of renal impairment in patients undergoing percutaneous coronary intervention in the drug-eluting stent era. Circ Cardiovasc Interv 2(4):309-316
24. Latif F, Kleiman NS, Cohen DJ et al (2009) In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: A report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. J Am Coll Cardiol Cardiovasc Interv 2:37-45
25. Tsai TT, Maddox TM, Roe MT et al (2009) Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention. JAMA 302:2458-2464